Sort
8,912 grants matching “sars cov 2”
SBIR Phase I: Immunity Transfer by Magnetic Separation (COVID-19)
$255,993Isaac Finger-Baker · 42bio, Llc · · FY2020 · TIP
SBIR Phase I: A knowledge base and drug repurposing platform for COVID-19
$255,993Cristiana Iosef · Advaita Corporation · · FY2020 · TIP
SBIR Phase I: Novel COVID-19 Dual-function Therapeutic/Vaccine Product
$255,990Sang Van · Paramita Therapeutics, Inc. · · FY2021 · TIP
SBIR Phase I: Development of a novel peptide inhibitor of coronavirus papain-like protease as a prophylactic and anti-viral therapeutic for COVID19, administered by inhalation
$255,981Avital Weiss · Grit Bio Inc · · FY2021 · TIP
SBIR Phase I: Rapid Solution to COVID-19 and Future Viral Pandemics
$255,973Timothy Childs · Tlc Millimeter Wave Products Inc. · · FY2021 · TIP
Role of SARS-CoV-2-mediated Type I IFN antagonism in individuals with Down Syndrome
$255,946Dusan Bogunovic · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AI
SBIR Phase I: Rapid disinfection using compact plasma reactors for COVID-19
$255,945Bhaswati Choudhury · Surfplasma, Inc. · · FY2020 · TIP
Inflammatory and Metabolic Biomarkers in Cardiovascular Complications with SARS-CoV-2
$255,940Svati H. Shah · Duke University · R21 · FY2021 · AI
STTR Phase I: Microbial Discovery and Biosynthesis of Targeted Protease Inhibitors (COVID-19)
$255,937Levi D Kramer · Think Bioscience, Inc. · · FY2020 · TIP
STTR Phase I: Designer peptide opsonins against COVID-19
$255,933Corey Heffernan · Saphtx, Inc. · · FY2020 · TIP
Transient Gene Therapy as Broad Spectrum Antiviral
$255,932Dusan Bogunovic · Lab11 Therapeutics, Llc · R41 · FY2021 · AI
SBIR Phase I: Microparticle reagents for clonal selection of producer cell lines
$255,916Joseph De Rutte · Partillion Bioscience Corporation · · FY2021 · TIP
Integrated Analysis of SARS-CoV-2 Vaccine Responses During Aging
$255,860Peter The Sage · Brigham And Women'S Hospital · R21 · FY2021 · AI
SBIR Phase I: Ultra-High Throughput COVID-19 Serology Test Using a Novel Biomarker Multiplexing System
$255,851Casey D Wright · Inanovate, Inc. · · FY2020 · TIP
COVID-19, heavy drinking and alcohol use disorders: a national study of Veterans Administration patients
$255,746Deborah S. Hasin · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R21 · FY2022 · AA
SBIR Phase I:Automatic Touch Screen Disinfection (COVID-19)
$255,730Boris Kobrin · Innovasonic · · FY2021 · TIP
Organ-on-Chip Approach for Assessing Tissue-specific SARS-CoV-2 Infection and Response to Antiviral Therapy
$255,716Thomas Neumann · Nortis, Inc. · R44 · FY2020 · TR
SBIR Phase I: Rapid COVID-19 diagnostics with CMOS-integrated single-molecule field-effect transistors
$255,678Erik F Young · Quicksilver Biosciences, Inc. · · FY2020 · TIP
SBIR Phase I: Development of a Novel Biosensor to Accelerate Investigations of COVID-19 and the Gut Microbiome.
$255,658Dylan Nichols · Biomesense, Inc. · · FY2021 · TIP
Clinical Core
$255,598David D. McManus · Univ Of Massachusetts Med Sch Worcester · U54 · FY2023 · HL
Clinical Core
$255,597David D. McManus · Univ Of Massachusetts Med Sch Worcester · U54 · FY2025 · HL
STTR Phase I: A platform for the rapid discovery of human antibodies as therapeutics for infectious disease (COVID-19)
$255,595Bradley E Poulsen · Altigg Therapeutics, Inc. · · FY2021 · TIP
SBIR Phase I: Machine Learning for Early Detection of COVID-19 Plaques in Cells
$255,571Ilya G Goldberg · Viqi Llc · · FY2020 · TIP
A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes
$255,563George L King · Joslin Diabetes Center · R21 · FY2022 · MD
STTR Phase I: Rapid Acting Disinfectant Spray for Slowing the Spread of COVID-19
$255,536Christina Drake · Kismet Technologies Inc. · · FY2020 · TIP